LC
ABMD

Lindbrook Capital’s Abiomed Inc ABMD Stock Holding History

Lindbrook Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-94
Closed -$23K – 3066
2022
Q3 		$23K Buy
94
+77
+453% +$20.8K ﹤0.01% 934
2022
Q2 		$4K Sell
17
-2
-11% -$540 ﹤0.01% 1721
2022
Q1 		$6K Buy
19
+2
+12% +$616 ﹤0.01% 1557
2021
Q4 		$6K Sell
17
-2
-11% -$676 ﹤0.01% 1477
2021
Q3 		$6K Hold
19
– – ﹤0.01% 1218
2021
Q2 		$6K Buy
19
+9
+90% +$2.76K ﹤0.01% 1268
2021
Q1 		$3K Buy
10
+4
+67% +$1.28K ﹤0.01% 1489
2020
Q4 		$2K Buy
6
+2
+50% +$553 ﹤0.01% 1543
2020
Q3 		$1K Hold
4
– – ﹤0.01% 1702
2020
Q2 		$1K Hold
4
– – ﹤0.01% 1671
2020
Q1 		$1K Buy
+4
New +$664 ﹤0.01% 1629
2019
Q3 		– Sell
-3
Closed – – 1564
2019
Q2 		$0 Hold
3
– – ﹤0.01% 1541
2019
Q1 		$0 Hold
3
– – ﹤0.01% 1534
2018
Q4 		$0 Buy
+3
New +$1.04K ﹤0.01% 1459

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's ABMD Position: Q4 2022 in Review

Lindbrook Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 94 shares — an estimated $23K sold.

Lindbrook Capital first reported a position in ABMD in Q4 2018 and held it in 14 quarters. The position peaked at $23K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Lindbrook Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Lindbrook Capital sold 94 Abiomed Inc shares in Q4 2022, an estimated $23K.
  • Lindbrook Capital first reported a position in Abiomed Inc in Q4 2018 and held it in 14 quarters.
  • Lindbrook Capital's Abiomed Inc position peaked at $23K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.